首页> 外文期刊>Journal of viral hepatitis. >Impact of electronic reminder systems on hepatitis C screening in primary care
【24h】

Impact of electronic reminder systems on hepatitis C screening in primary care

机译:电子提醒系统对初级保健丙型肝炎筛选的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Summary Screening for hepatitis C virus (HCV) was recommended in 2012 by the Centers for Disease Control (CDC) for the population born between 1946 and 1965. Reminder systems are effective at promoting HCV screening, but the yield of positive tests among various population subgroups and the linkage to specialty HCV treatment is not well understood. We sought to determine: (i) the effect of the CDC recommendation alone, and the effect of an electronic medical record (EMR) reminder on the proportion of the population screened; (ii) the yield of positive HCV tests as screening strategies have evolved, and according to a patient's history of serum aminotransferase testing; (iii) the proportion of positive cases followed up for HCV treatment. This retrospective cohort study included 60?000 primary care patients at a northeast US academic medical centre serving an urban and rural population in which an EMR reminder was instituted in 2014. Results demonstrated an increase in proportion tested for HCV from 12% prior to the CDC recommendation to 37% after the reminder system. The yield of positive HCV antibody (HCV Ab) tests decreased from 7% in the “case‐finding” era to 1.6% after the EMR reminder prompted screening of a lower risk population ( P ??.001). Patients with a history of abnormal aminotransferase tests had a fivefold higher rate of positive HCV Ab testing (6.7% vs 1.5%, P ??.001). Ninety per cent of patients with confirmed HCV infection were seen in specialty care.
机译:概述筛查丙型肝炎病毒(HCV)由1946年至1965年之间出生的人口的疾病控制中心(CDC)。提醒系统在促进HCV筛查方面有效,但各种人口亚组之间的阳性测试产量有效与特种HCV治疗的联系尚不清楚。我们试图确定:(i)单独的CDC建议的效果,以及电子医疗记录(EMR)提醒对筛查人口比例的影响; (ii)作为筛选策略的阳性HCV试验的产率已经发展,并根据患者血清氨基转移酶测试的历史; (iii)阳性病例的比例随访HCV治疗。这项回顾性的队列研究包括在美国东北部的60 000名初级护理患者,该患者在2014年提供了一个城市和农村人口的城乡人口。结果在CDC之前从12%的HCV中测试了比例增加的结果提醒系统后建议达到37%。阳性HCV抗体(HCV AB)的产率在EMR提醒促进筛选风险群体(Pα.001)后,在“案例发现”时的阳性HCV抗体(案例 - 发现“ERA中的7%降低至1.6%。患有异常转移酶试验的历史的患者具有较高的阳性HCV AB测试率(6.7%Vs 1.5%,p≤001)。特种护理中观察到百分之九十条确诊的HCV感染患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号